Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Rosiglitazone and Alpha-lipoic Acid on NASH
NCT01406704Phase 4Terminated
- Sponsor
- Seoul St. Mary's Hospital
- Start
- Jan 2004
- Primary completion
- Dec 2010
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rosiglitazone, alpha-lipoic acid in Nonalcoholic steatohepatitis (NASH), sponsored by Seoul St. Mary's Hospital. Started Jan 2004; status: terminated.
02
Drugs
rosiglitazonealpha-lipoic acid
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT01406704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01406704.